Link to this page
The Drug-Drug Interactions Ontology
Last uploaded:
February 11, 2016
| Id | http://purl.obolibrary.org/obo/dinto_DB00056
http://purl.obolibrary.org/obo/dinto_DB00056
|
|---|---|
| Preferred Name | gemtuzumab ozogamicin |
| Type | http://www.w3.org/2002/07/owl#Class |
All Properties
| prefLabel | gemtuzumab ozogamicin
|
|---|---|
| label | gemtuzumab ozogamicin
|
| DBSynonym |
mylotarg
anti-cd33
|
| Definition | Recombinant humanized IgG4, kappa antibody conjugated with a cytotoxic antitumor antibiotic, calicheamicin, isolated from fermentation of a bacterium, Micromonospora echinospora ssp. calichensis. The antibody portion of Mylotarg binds specifically to the CD33 antigen, The anti-CD33 hP67.6 antibody is produced by mammalian cell suspension culture using a myeloma NS0 cell line.
|
| has pharmacological target | |
| type | |
| xref |
RxList:http://www.rxlist.com/cgi/generic2/gemtuzumab.htm
PharmGKB:PA164749431
Wikipedia:http://en.wikipedia.org/wiki/Gemtuzumab_ozogamicin
Drugs.com:http://www.drugs.com/cdi/gemtuzumab-ozogamicin.html
National Drug Code Directory:0008-4510-01
|
| CASRN | 220578-59-6
|
| prefixIRI | obo2:dinto_DB00056
|
| related with |
See more
See less
|
| DBBrand |
mylotarg (wyeth)
mylotarg
|
| subClassOf |
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |